GlassScriptPhysician profile
Aaron Fujimoto
NPI 1477127314
$853.12
in general payments reported to CMS, 2019-2025
10 companies · $714 in 2025
The $714 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.70 · 2024: $122 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $334.60 | 2025 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.65 | 2025 | Jardiance |
| Vanda Pharmaceuticals INC. | $124.46 | 2025 | Fanapt, Ponvory |
| Lilly USA, LLC | $54.72 | 2023-2024 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $48.15 | 2024-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $35.19 | 2024 | |
| Alexion Pharmaceuticals, INC. | $21.68 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $20.78 | 2025 | |
| Abbvie INC. | $18.02 | 2024 | |
| Indivior INC. | $13.87 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Fujimoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.